Assignee
STALLERGENES
FR·6 granted patents·2 pending applications·0 citations·filing 2002–2017
Top patents by PatentIndex Score
8 records- 0156US11027010B2Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoidsSTALLERGENES·Filed 2017·Granted Jun 8, 2021·0 cites·4 claims
- 0245US7285650B2Cloning and sequencing of the allergen Dac g5 of Dactylis glomerata pollen, its preparation and its useSTALLERGENES·Filed 2002·Granted Oct 23, 2007·0 cites·13 claims
- 0344US10610586B2Compositions for antigen-specific induction of toleranceSTALLERGENES·Filed 2016·Granted Apr 7, 2020·0 cites·16 claims
- 0439US11028441B2IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapySTALLERGENES·Filed 2017·Granted Jun 8, 2021·0 cites·4 claims
- 0537US11015221B2Markers of immune responseSTALLERGENES·Filed 2015·Granted May 25, 2021·0 cites·3 claims
- 0636US2017157240A1Composition of allergen extracts having reduced toxicity and method of production thereofSTALLERGENES·Filed 2015·Application pending·0 cites
- 0734US2016367631A1C1q as a therapeutic agent of allergy and/or asthmaSTALLERGENES·Filed 2014·Application pending·0 cites
- 0833US10884002B2Sialylated fetuin-A as a marker of immunotherapy efficacySTALLERGENES·Filed 2015·Granted Jan 5, 2021·0 cites·8 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →